Antibiotice S.A. (BVB:ATB)
Romania
· Delayed Price · Currency is RON 1.782
-0.030 (-1.66%)
At close: Apr 28, 2026
Antibiotice Cash Flow Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 51.77 | 102.2 | 81.09 | 51.47 | 29.94 | Upgrade
|
| Depreciation & Amortization | 54.2 | 45.06 | 27.93 | 22.57 | 24.43 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.16 | -0 | 2.75 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 3.04 | - | Upgrade
|
| Provision & Write-off of Bad Debts | -6.2 | 3 | -1.1 | -3.14 | - | Upgrade
|
| Other Operating Activities | 0.12 | -6.57 | 2.81 | 17.4 | -9.93 | Upgrade
|
| Change in Accounts Receivable | -5.15 | -65.3 | -30.64 | 75.98 | - | Upgrade
|
| Change in Inventory | -8.37 | -1.78 | -19.05 | -40.84 | - | Upgrade
|
| Change in Unearned Revenue | - | 0.16 | 0 | 0.03 | - | Upgrade
|
| Change in Other Net Operating Assets | -13.94 | 18.54 | 61.42 | -13.6 | - | Upgrade
|
| Operating Cash Flow | 72.44 | 95.15 | 122.46 | 115.66 | 44.44 | Upgrade
|
| Operating Cash Flow Growth | -23.87% | -22.30% | 5.88% | 160.28% | -52.75% | Upgrade
|
| Capital Expenditures | -142.61 | -98.77 | -83.03 | -37.58 | -29.05 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -17.39 | -15.01 | -7.47 | - | Upgrade
|
| Other Investing Activities | 5.34 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -137.27 | -116.16 | -98.04 | -45.05 | -29.05 | Upgrade
|
| Long-Term Debt Issued | 92.51 | 85.19 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -10.79 | -14.68 | -63.8 | -6.32 | Upgrade
|
| Net Debt Issued (Repaid) | 92.51 | 74.41 | -14.68 | -63.8 | -6.32 | Upgrade
|
| Common Dividends Paid | -15.95 | -48.17 | -5.43 | -3.43 | -2.1 | Upgrade
|
| Other Financing Activities | -4.46 | -4.61 | -4.09 | -3.53 | - | Upgrade
|
| Financing Cash Flow | 72.1 | 21.63 | -24.2 | -70.76 | -8.42 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.25 | -0.14 | -0.26 | -0.1 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | -0 | 0.02 | - | Upgrade
|
| Net Cash Flow | 7.26 | 0.87 | 0.08 | -0.38 | 6.87 | Upgrade
|
| Free Cash Flow | -70.17 | -3.63 | 39.43 | 78.09 | 15.39 | Upgrade
|
| Free Cash Flow Growth | - | - | -49.50% | 407.53% | -66.60% | Upgrade
|
| Free Cash Flow Margin | -10.63% | -0.53% | 6.41% | 15.46% | 4.06% | Upgrade
|
| Free Cash Flow Per Share | -0.10 | -0.01 | 0.06 | 0.12 | 0.02 | Upgrade
|
| Cash Interest Paid | 4.47 | 4.61 | 4.09 | 3.53 | 3.54 | Upgrade
|
| Cash Income Tax Paid | 6.64 | 3.72 | 13.02 | 3.93 | 3.61 | Upgrade
|
| Levered Free Cash Flow | -99.14 | -60.04 | -6 | 44.45 | 21.61 | Upgrade
|
| Unlevered Free Cash Flow | -96.34 | -57.2 | -3.4 | 46.69 | 23.81 | Upgrade
|
| Change in Working Capital | -27.46 | -48.38 | 11.73 | 21.57 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.